Global Breast Ultrasound Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

Breast Ultrasound Market Size

• The global breast ultrasound market size was valued at USD 2.67 billion in 2025 and is expected to reach USD 6.24 billion by 2033, at a CAGR of 11.20% during the forecast period
• The market growth is largely fueled by the increasing incidence of breast cancer worldwide, rising emphasis on early diagnosis, and the expanding adoption of non-invasive imaging modalities across hospitals and diagnostic centers
• Furthermore, advancements in automated breast ultrasound (ABUS), AI-enabled imaging, and improved workflow efficiency are strengthening demand for accurate, user-friendly, and accessible diagnostic solutions, establishing breast ultrasound as a critical tool in global breast cancer detection and screening programs

Breast Ultrasound Market Analysis

• Breast ultrasound, offering non-invasive imaging for the detection and evaluation of breast abnormalities, is becoming an increasingly vital component of global breast cancer screening and diagnostic pathways due to its effectiveness in imaging dense breast tissue, real-time visualization, and ability to complement mammography for improved diagnostic accuracy
• The escalating demand for breast ultrasound is primarily fueled by the rising global incidence of breast cancer, increasing awareness of early detection, and growing adoption of automated and AI-enhanced ultrasound systems that improve accuracy, reduce operator dependency, and enhance workflow efficiency across healthcare settings
• North America dominated the breast ultrasound market with the largest revenue share of 40.2% in 2025, supported by advanced healthcare infrastructure, high screening rates, rapid adoption of technologically advanced ultrasound platforms, and a strong presence of leading imaging device manufacturers, with the U.S. experiencing substantial growth in both conventional and automated ultrasound installations across hospitals and diagnostic centers
• Asia-Pacific is expected to be the fastest-growing region in the breast ultrasound market during the forecast period due to increasing awareness of breast cancer screening, expanding healthcare access, rising healthcare expenditure, and growing adoption of cost-effective ultrasound systems in hospitals and diagnostic facilities
• Conventional breast sonography dominated the breast ultrasound market with a share of 62.7% in 2025, driven by its widespread clinical use, affordability, and established presence across healthcare systems

Report Scope and Breast Ultrasound Market Segmentation  

Breast Ultrasound Market Trends

Advancing Integration of AI and Automated Imaging

• A significant and accelerating trend in the global breast ultrasound market is the growing adoption of AI-assisted imaging and automated breast ultrasound (ABUS) systems, enhancing lesion detection accuracy, workflow efficiency, and operator independence
  • For instance, GE Healthcare’s Invenia ABUS system combines automated scanning with AI-based lesion analysis, enabling radiologists to detect abnormalities in dense breast tissue more reliably and efficiently
• AI integration in breast ultrasound allows for features such as pattern recognition, predictive analysis, and intelligent reporting, helping clinicians prioritize high-risk cases and reduce diagnostic errors. For instance, Siemens Healthineers’ AI-enabled ultrasound platforms can flag suspicious lesions and provide diagnostic support
• The seamless integration of automated and AI-enhanced systems with hospital PACS and diagnostic platforms facilitates centralized image management, enabling radiologists to review, analyze, and store imaging data in a unified environment
• This trend towards more intelligent, accurate, and efficient breast imaging systems is reshaping expectations for cancer screening, as companies such as Hologic develop AI-enhanced ABUS solutions capable of automated lesion detection and improved workflow
• The demand for AI-integrated and automated breast ultrasound systems is growing rapidly across hospitals and diagnostic centers, as healthcare providers prioritize early and precise detection of breast abnormalities
• Emerging tele-ultrasound solutions are enabling remote imaging and interpretation, expanding access to breast ultrasound in underserved and rural areas
• Integration of contrast-enhanced ultrasound (CEUS) techniques with AI is enabling more precise characterization of lesions, improving diagnostic confidence and reducing unnecessary biopsies

Breast Ultrasound Market Dynamics

Driver

Rising Breast Cancer Incidence and Screening Awareness

• The increasing prevalence of breast cancer worldwide, combined with growing awareness about the importance of early detection, is a major driver for the breast ultrasound market
  • For instance, in 2025, the American Cancer Society highlighted the rising need for accessible screening tools, promoting adoption of ultrasound in conjunction with mammography for comprehensive breast evaluation
• As healthcare providers seek to improve diagnostic accuracy and reduce false negatives, breast ultrasound offers non-invasive, real-time imaging that complements traditional mammography
• Furthermore, the expansion of screening programs, especially in hospitals and diagnostic centers, is boosting demand for both conventional and automated ultrasound systems
• The convenience of non-invasive imaging, real-time results, and the ability to detect lesions in dense breast tissue are key factors driving adoption among radiologists and clinicians
• Increasing investments in advanced ultrasound technologies and AI-enabled platforms for hospitals and diagnostic facilities are propelling market growth globally
• Government initiatives and reimbursement policies supporting early breast cancer detection are further accelerating the adoption of ultrasound-based screening tools
• Rising public-private partnerships and collaborations for mobile screening programs in developing regions are expanding breast ultrasound access and driving market growth

Restraint/Challenge

High Equipment Costs and Training Requirements

• The relatively high initial cost of advanced breast ultrasound systems, especially automated and AI-enabled platforms, is a significant restraint on market penetration, particularly in developing regions
  • For instance, small diagnostic centers or rural hospitals may face budget constraints, limiting their ability to adopt state-of-the-art ABUS or AI-integrated systems
• In addition, specialized training is required to operate automated and AI-enhanced ultrasound systems effectively, which can slow adoption among staff with limited technical expertise
• Limited access to skilled sonographers and radiologists in certain regions may reduce the effective utilization of advanced imaging technologies
• While conventional ultrasound remains affordable and widely available, the premium pricing for automated or AI-assisted platforms can hinder adoption in price-sensitive markets
• Overcoming these challenges through cost reduction, training programs, and scalable technology solutions will be critical for sustained market growth globally
• Maintenance and servicing costs for sophisticated ultrasound machines can be high, creating additional financial burdens for smaller healthcare providers
• Regulatory approvals and varying compliance standards across regions may delay the launch and adoption of new ultrasound technologies, limiting market expansion

Breast Ultrasound Market Scope

The market is segmented on the basis of technology and end user.

• By Technology

On the basis of technology, the breast ultrasound market is segmented into conventional breast sonography (CBS) and automated whole breast ultrasound (ABUS). The conventional breast sonography segment dominated the market with the largest revenue share of 62.7% in 2025, driven by its widespread clinical adoption and cost-effectiveness. Hospitals and diagnostic centers continue to rely on CBS due to its proven accuracy in routine breast imaging and the availability of skilled sonographers trained in its use. CBS offers flexibility across patient types and can be easily integrated into existing imaging workflows without significant additional investment. The segment benefits from a large installed base of ultrasound machines worldwide, which supports its continued preference among clinicians. Its affordability compared to automated systems makes it the primary choice in developing regions and smaller healthcare facilities. In addition, CBS provides real-time imaging and high patient throughput, ensuring efficient examination and rapid diagnosis, which reinforces its market dominance.

The ABUS segment is anticipated to witness the fastest growth, at a CAGR of ≈14–15% from 2026 to 2033, driven by its enhanced accuracy in detecting lesions, especially in dense breast tissue. ABUS provides automated, reproducible scanning and reduces operator dependency, which improves diagnostic confidence and efficiency. For instance, ABUS systems are increasingly adopted in large hospitals and screening centers to complement mammography, offering comprehensive breast evaluation. The integration of AI-assisted analysis with ABUS enhances lesion detection, prioritizes high-risk cases, and accelerates workflow for radiologists. Rising awareness among clinicians about the limitations of conventional ultrasound in dense tissue is driving ABUS adoption. Moreover, favorable reimbursement policies and government-supported breast cancer screening programs in developed regions are accelerating ABUS deployment, making it the fastest-growing technology subsegment.

• By End User

On the basis of end user, the breast ultrasound market is segmented into hospitals, ambulatory surgical units (ASUs), and diagnostic centers. Hospitals dominated the market with a revenue share of 52.1% in 2025, owing to high patient footfall, comprehensive diagnostic services, and continuous investments in advanced imaging technologies. Hospitals require both conventional and automated ultrasound systems to support routine examinations, screening programs, and follow-up procedures. They often serve as referral centers for complex cases, making breast ultrasound an essential diagnostic tool. The availability of skilled radiologists and trained sonographers ensures accurate interpretation of images, reinforcing hospital preference for both CBS and ABUS systems. In addition, hospitals benefit from higher budgets to adopt AI-integrated and automated imaging solutions, improving workflow efficiency and diagnostic outcomes. The need for high-volume patient throughput further drives demand for robust and reliable breast ultrasound systems within hospital settings.

Diagnostic centers are expected to witness the fastest growth during the forecast period due to the increasing focus on outpatient and preventive healthcare services. These centers are investing in both conventional and automated breast ultrasound technologies to offer specialized, cost-effective screening solutions. For instance, private diagnostic facilities are increasingly using ABUS systems to attract patients seeking high-accuracy imaging with minimal waiting times. Rising awareness of breast cancer screening among urban populations is contributing to higher patient inflow at diagnostic centers. The convenience, accessibility, and flexible operating hours of diagnostic centers make them attractive alternatives to hospital visits, fueling segment growth. Furthermore, partnerships with insurance providers and government-supported screening initiatives are enabling diagnostic centers to expand their services, positioning them as the fastest-growing end-user segment in the market.

Breast Ultrasound Market Regional Analysis

• North America dominated the breast ultrasound market with the largest revenue share of 40.2% in 2025, supported by advanced healthcare infrastructure, high screening rates, rapid adoption of technologically advanced ultrasound platforms, and a strong presence of leading imaging device manufacturers
• Healthcare providers in the region highly value the accuracy, non-invasive nature, and real-time imaging capabilities offered by breast ultrasound, particularly in dense breast tissue, complementing mammography for early detection and diagnosis
• This widespread adoption is further supported by high healthcare expenditure, availability of skilled radiologists and sonographers, and the strong presence of leading imaging device manufacturers, establishing breast ultrasound as a preferred diagnostic tool in hospitals and diagnostic centers across both the U.S. and Canada.

U.S. Breast Ultrasound Market Insight

The U.S. breast ultrasound market captured the largest revenue share of 81% in North America in 2025, fueled by the widespread adoption of advanced imaging technologies and well-established breast cancer screening programs. Healthcare providers are increasingly prioritizing early detection and accurate diagnostics through the use of both conventional and automated breast ultrasound systems. The growing preference for AI-assisted imaging and integration with hospital PACS and reporting systems further propels market growth. Moreover, rising awareness among women regarding breast health, along with government initiatives promoting preventive screening, is significantly contributing to the market expansion. The high number of hospitals and diagnostic centers equipped with state-of-the-art imaging devices also supports continued market dominance.

Europe Breast Ultrasound Market Insight

The Europe breast ultrasound market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by rising breast cancer incidence and increased demand for early detection technologies. Adoption is supported by government-led screening programs and reimbursement schemes encouraging routine ultrasound screening. European healthcare providers are also investing in AI-enabled and automated systems to improve diagnostic accuracy and efficiency. The increase in urban healthcare infrastructure, coupled with growing patient awareness about breast health, is fostering the adoption of advanced imaging solutions. The market is witnessing significant growth across hospitals, diagnostic centers, and outpatient clinics, with ultrasound being incorporated into both new installations and upgraded imaging facilities.

U.K. Breast Ultrasound Market Insight

The U.K. breast ultrasound market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by heightened awareness of breast cancer screening and preventive healthcare practices. Increasing demand for accurate and non-invasive diagnostic tools is encouraging hospitals and diagnostic centers to adopt both conventional and automated ultrasound systems. In addition, the integration of AI and improved imaging technologies is helping clinicians detect abnormalities more efficiently, reducing diagnostic errors. The U.K.’s well-established healthcare infrastructure and focus on patient-centered care are expected to continue stimulating market growth. Rising government initiatives and funding for breast cancer awareness and screening programs further support market expansion.

Germany Breast Ultrasound Market Insight

The Germany breast ultrasound market is expected to expand at a considerable CAGR during the forecast period, fueled by increasing awareness of early breast cancer detection and investment in technologically advanced imaging solutions. German healthcare providers are emphasizing the adoption of AI-assisted and automated breast ultrasound systems to improve diagnostic accuracy and workflow efficiency. Hospitals and diagnostic centers are increasingly integrating ultrasound systems with PACS and hospital information systems to centralize imaging management. Germany’s strong focus on innovation, high healthcare expenditure, and demand for reliable and precise diagnostic tools promote the adoption of advanced breast ultrasound solutions. The preference for non-invasive, safe, and eco-conscious imaging technologies aligns with local consumer expectations, further driving market growth.

Asia-Pacific Breast Ultrasound Market Insight

The Asia-Pacific breast ultrasound market is poised to grow at the fastest CAGR of 24% during 2026 to 2033, driven by rising breast cancer awareness, increasing healthcare access, and technological advancements in countries such as China, Japan, and India. The region’s growing inclination towards preventive healthcare, supported by government initiatives and national screening programs, is accelerating the adoption of breast ultrasound systems. The expansion of hospitals, diagnostic centers, and mobile screening units enhances accessibility to breast imaging. Furthermore, as APAC emerges as a manufacturing and innovation hub for imaging devices, affordability and availability of breast ultrasound systems are increasing for a wider population.

Japan Breast Ultrasound Market Insight

The Japan breast ultrasound market is gaining momentum due to high awareness of breast cancer, a strong focus on early detection, and the adoption of advanced imaging technologies. The integration of AI and automated ultrasound solutions in hospitals and diagnostic centers enhances lesion detection and reduces diagnostic errors. Rapid urbanization and a high number of healthcare facilities contribute to increased market penetration. Moreover, Japan’s aging population is such asly to spur demand for easy-to-use, non-invasive, and accurate diagnostic tools in both residential and clinical healthcare settings.

India Breast Ultrasound Market Insight

The India breast ultrasound market accounted for the largest market revenue share in Asia-Pacific in 2025, attributed to the country’s expanding middle class, increasing healthcare awareness, and rapid urbanization. Hospitals and diagnostic centers are investing in both conventional and automated ultrasound systems to meet the growing demand for early breast cancer detection. Government initiatives promoting preventive healthcare and breast cancer screening programs are boosting adoption. Affordable imaging solutions and the presence of domestic manufacturers further facilitate market growth. The increasing number of private diagnostic centers and hospitals equipped with advanced ultrasound systems is supporting continued expansion of the breast ultrasound market in India.

Breast Ultrasound Market Share

The Breast Ultrasound industry is primarily led by well-established companies, including:

• GE HealthCare (U.S.)
• Siemens Healthineers AG (Germany)
• Koninklijke Philips N.V. (Netherlands)
• CANON MEDICAL SYSTEMS CORPORATION (Japan)
• Hitachi, Ltd. (Japan)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
• Samsung Medison Co., Ltd. (South Korea)
• Esaote S.p.A. (Italy)
• Fujifilm SonoSite, Inc. (U.S.)
• Hologic, Inc. (U.S.)
• Analogic Corporation (U.S.)
• Teratech Corporation (U.S.)
• SonoScape Medical Corporation (China)
• Clarius Mobile Health Corp. (Canada)
• SIUI (China)
• ALPINION Medical Systems Co., Ltd. (South Korea)
• Zonare Medical Systems, Inc. (U.S.)
• Neusoft Medical Systems Co., Ltd. (China)
• Bracco Imaging (Italy)
• MedGyn Products, Inc. (U.S.)

What are the Recent Developments in Global Breast Ultrasound Market?

• In December 2025, DeepHealth (a subsidiary of RadNet, Inc.) announced the launch of DeepHealth Breast Suite, a modular AI‑powered platform combining cancer detection, breast density assessment, risk stratification, and integrated reporting/workflow tools effectively merging mammogram, ultrasound, and diagnostic data streams to boost detection accuracy and streamline clinical workflow
• In March 2025, GE HealthCare launched Invenia ABUS Premium, a new AI‑enabled 3D automated breast‑ultrasound (ABUS) system tailored for supplemental screening in dense breasts. The system offers faster scans improved image resolution, AI‑driven “Scan Quality Assessment,” and tools to standardize acquisition and reading workflows a major step forward for breast ultrasound screening
• In March 2025, multiple medical-imaging outlets highlighted that Invenia ABUS Premium is the first FDA‑approved breast ultrasound system specifically indicated for supplemental screening in dense breasts reinforcing regulatory acceptance and paving the way for wider clinical adoption
• In June 2024, researchers from Denmark demonstrated that using AI to assist in breast cancer screening improved detection rates while reducing false positives. In their study, AI‑guided screening resulted in fewer recalls and a lower radiologist workload, suggesting AI has real potential to enhance screening efficiency and accuracy
• In July 2023, Carle Health announced that they began offering Invenia ABUS 2.0 (Automated Breast Ultrasound System) at their Women’s Diagnostic Center marking a concrete expansion of ABUS availability beyond large academic medical centers. This underscores growing acceptance and deployment of automated ultrasound screening in community-level diagnostic center

SKU-44840